Literature DB >> 27394182

Association between lipoprotein(a) and nonalcoholic fatty liver disease among Korean adults.

Ji Sun Nam1, Sehee Jo2, Shinae Kang1, Chul Woo Ahn1, Kyung Rae Kim2, Jong Suk Park3.   

Abstract

BACKGROUND: Lipoprotein(a) [Lp(a)] and nonalcoholic fatty liver disease (NAFLD) are risk factors for cardiovascular diseases. We investigated the relationship between Lp(a) concentrations and NAFLD among Korean adults.
METHODS: A total of 2242 nondiabetic subjects undergoing routine health screening examination were enrolled. Anthropometric and biochemical parameters, including Lp(a) were measured. NAFLD were assessed by ultrasonography. Adjusted Odds ratios for the presence of NAFLD according to Lp(a) tertiles were estimated using logistic regression.
RESULTS: Subjects were grouped according to the severity of NAFLD and Lp(a) concentrations. Lp(a) concentrations were decreased across the severity of NAFLD and the prevalence of NAFLD decreased with the Lp(a) tertiles. Compared with subjects in the lowest tertile of Lp(a), those in the highest tertile had higher total cholesterol and LDL-C concentrations and lower body mass index, blood pressure, fasting glucose, triglyceride, ALT, and HOMA-IR concentrations. In the logistic regression analysis after adjusting for multiple risk factors, the relationship between Lp(a) concentrations and the presence of NAFLD remained significant. However, this association was attenuated after adjusting for insulin resistance.
CONCLUSIONS: Lp(a) was inversely associated with the presence of NAFLD, but it was not an independent risk factor for NAFLD among Korean adults.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Insulin resistance; Lipoprotein(a); Nonalcoholic fatty liver disease

Mesh:

Substances:

Year:  2016        PMID: 27394182     DOI: 10.1016/j.cca.2016.07.003

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  Lipoprotein(a) is Associated with Cardiovascular Events in Low Risk Males: Results from a Health Checkup Cohort with Long-Term Follow-Up.

Authors:  Yi-Chun Huang; Yu-Wen Cheng; Victor Chien-Chia Wu; Chia-Pin Lin; Yi-Wei Kao; Pao-Hsien Chu; Yu-Sheng Lin
Journal:  Acta Cardiol Sin       Date:  2022-05       Impact factor: 1.800

2.  Study on the relationship between hormone and Lp(a) in Chinese overweight/obese patients.

Authors:  Xiaona Chang; Nannan Bian; Xiaoyu Ding; Jinman Li; Yu An; Jiaxuan Wang; Jia Liu; Guang Wang
Journal:  BMC Endocr Disord       Date:  2022-05-16       Impact factor: 3.263

3.  Implication between Genetic Variants from APOA5 and ZPR1 and NAFLD Severity in Patients with Hypertriglyceridemia.

Authors:  Virginia Esteve-Luque; Ariadna Padró-Miquel; Marta Fanlo-Maresma; Emili Corbella; Xavier Corbella; Xavier Pintó; Beatriz Candás-Estébanez
Journal:  Nutrients       Date:  2021-02-08       Impact factor: 5.717

4.  Lipoprotein A, combined with alanine aminotransferase and aspartate aminotransferase, contributes to predicting the occurrence of NASH: a cross-sectional study.

Authors:  Yu Zhang; He He; Yu-Ping Zeng; Li-Dan Yang; Dan Jia; Zhen-Mei An; Wei-Guo Jia
Journal:  Lipids Health Dis       Date:  2020-06-11       Impact factor: 3.876

5.  Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Marica Meroni; Miriam Longo; Rosa Lombardi; Erika Paolini; Chiara Macchi; Alberto Corsini; Cesare R Sirtori; Anna Ludovica Fracanzani; Massimiliano Ruscica; Paola Dongiovanni
Journal:  Hepatol Commun       Date:  2021-10-22

Review 6.  Non-genetic influences on lipoprotein(a) concentrations.

Authors:  Byambaa Enkhmaa; Lars Berglund
Journal:  Atherosclerosis       Date:  2022-05       Impact factor: 6.847

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.